Table of Content

Chapter 1: Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered in the study
1.3. Executive summary

Chapter 2: Introduction
2.1. Market definitions
2.2. Global market trends
2.3. Global drivers
2.4. Global challenges
2.5. Revenue based on product types – 2018 (USD Bn)
2.6. Revenue based on end users – 2018 (USD Bn)
2.7. Value chain of blood plasma products market

Chapter 3: Global Blood Plasma Products Market Overview
3.1. Market overview
3.1.a. Global historical market revenue – (2015-2017) (USD Bn)
3.1.b. Global forecast market revenue – (2018-2023) (USD Bn)
3.1.c. Geography-wise market revenue – (2018, 2023) (USD Bn)

Chapter 4: Global Blood Plasma Products Market – Based on Product Types
4.1. Global Immunoglobulin market
4.1.a. Market Overview
4.1.b. Regional Revenue Contribution
4.2. Global Albumin market
4.2.a. Market Overview
4.2.b. Regional Revenue Contribution
4.3. Global Hyperimmune Globulin market
4.3.a. Market Overview
4.3.b. Regional Revenue Contribution
4.4. Global Coagulation Factor VIII market
4.4.a. Market Overview
4.4.b. Regional Revenue Contribution
4.5. Global Coagulation Factor IX market
4.5.a. Market Overview
4.5.b. Regional Revenue Contribution
4.6. Global Other Plasma Products market
4.5.a. Market Overview
4.5.b. Regional Revenue Contribution

Chapter 5: Global Blood Plasma Products Market – Based on End Users
5.1. Global Hospitals market
4.1.a. Market Overview
4.1.b. Regional Revenue Contribution
5.2. Global Clinics market
4.2.a. Market Overview
4.2.b. Regional Revenue Contribution
5.3. Global Other End Users market
4.3.a. Market Overview
4.3.b. Regional Revenue Contribution

Chapter 6: Global Blood Plasma Products Market - Based on Regions
6.1. North America market
6.1.a. Market Overview by Product Types
6.1.b. Market Overview by End Users
6.2. Europe market
6.2.a. Market Overview by Product Types
6.2.b. Market Overview by End Users
6.3. Asia-Pacific market
6.3.a. Market Overview by Product Types
6.3.b. Market Overview by End Users
6.4. Latin America market
6.4.a. Market Overview by Product Types
6.4.b. Market Overview by End Users
6.5. The Middle-East and Africa market
6.5.a. Market Overview by Product Types
6.5.b. Market Overview by End Users

Chapter 7: Competitive Landscape
6.1. Major players: Market share analysis
6.2. CSL Behring
6.2.a. Company snapshot
6.2.b. Key financials
6.2.c. Business description
6.2.d. Major products
6.2.e. Growth strategies and major initiatives

Note: Similar information areas will be covered for the remaining competitors
6.2. Shire Plc
6.3. Grifols S.A.
6.4. Octapharma AG
6.5. ADMA Biologics
6.6. Kedrion Biopharma

Chapter 8: Conclusion

Chapter 9: Appendix
10.1. List of tables
10.2. Assumptions
10.2. Research methodology
10.3. About Research on Global Markets
10.4. Disclaimer